基本信息
浏览量:10
职业迁徙
个人简介
Multiple myeloma is the second most common haematological cancer, responsible for approximately 80,000 deaths per year, world-wide. While significant advances in myeloma treatment over the past decade have greatly improved survival rates for multiple myeloma, almost all patients eventually relapse and succumb to their disease. My studies are primarily aimed at identifying the molecular and cellular mechanisms responsible for rapid disease progression in those patients that do very poorly, surviving less than 2 years. Ultimately, these studies are aimed at developing targeted treatments to improve outcomes for these high-risk patients.
研究兴趣
论文共 66 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancer and Metastasis Reviewspp.1-15, (2024)
Charlotte Toomes, Barbara McClure, Giles Best,Lisa Ebert,Kate Vandyke,Michaelia Cockshell, Thomas Day, Craig Wallington-Gates,Claudine Bonder
Clinical Lymphoma Myeloma and Leukemia (2024): S199-S200
Leukemia research (2024): 107469-107469
crossref(2023)
crossref(2023)
crossref(2023)
Clinical lymphoma myeloma & leukemia/Clinical lymphoma, myeloma and leukemia (2023): S135-S135
crossref(2023)
crossref(2023)
加载更多
作者统计
#Papers: 66
#Citation: 1412
H-Index: 23
G-Index: 37
Sociability: 6
Diversity: 0
Activity: 1
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn